Trump’s Autism Announcement: Flimsy Evidence and Potential Lawsuits
During a recent White House announcement, President Trump advised pregnant individuals to avoid Tylenol due to potential autism links, while also promoting leucovorin, a treatment for autism currently backed by very limited scientific evidence. The administration’s guidance comes despite unclear connections between Tylenol and autism, and widespread medical advice to consult a doctor before taking the medicine. The announcement, however, overlooks the increasing autism rates being largely attributed to broader diagnostic criteria, and heightened public awareness, as well as the scientific focus on genetic factors. The White House’s actions have raised concerns among autism scientists, and advocates, who argue the guidance is not supported by current scientific research.
John Q. Hosedrinker